SYNERGICE
LIVE

Serial Number

98338186

Owner

Strides Pharma Science Limited

Attorney

Zach Gordon

Filing Date

Jan 2, 2024

Add to watchlist:

No watchlists yet
View on USPTO

SYNERGICE Trademark

Serial Number: 98338186

SYNERGICE is a trademark filed by Strides Pharma Science Limited on January 2, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Strides Pharma Science Limited (4 trademarks)

Bilekhalli, Bannerghatta Road
Bangalore 560076 , IN

Entity Type: 99

Trademark Details

Filing Date

January 2, 2024

Registration Date

Not Registered

Published for Opposition

December 24, 2024

Goods & Services

Business to business services in the nature of generating business leads, business development, providing business information, acting as single point of contact between clients and vendors for providing product and pricing information and facilitating commercial transactions, all of the forgoing in the field of generic pharmaceuticals

pharmaceutical preparations for treatment of Musculo skeletal pain; pharmaceutical preparations for treatment of cancer; pharmaceutical preparations for treatment of Psychiatric disorders; pharmaceutical preparations for treatment of human immunodeficiency virus (HIV); pharmaceutical preparations for treatment Gastro Intestinal illnesses and disorders; pharmaceutical preparations for treatment of allergies; pharmaceutical preparations for treatment of viral illnesses; pharmaceutical preparations for treatment of bacterial illnesses; pharmaceutical preparations for diabetes management; pharmaceutical preparations for treatment of gout; pharmaceutical preparations for treatment of fungal infections; pharmaceutical preparations for treatment of attention deficit disorder; pharmaceutical preparations for treatment of immune disorders; pharmaceutical preparations for treatment of neurological disorders and neurological illness; pharmaceutical preparations for treatment of cardiovascular illnesses; pharmaceutical preparations for treatment of urological issues; pharmaceutical preparations for treatment of sleep disorders; pharmaceutical preparations for treatment of sexual disorders; pharmaceutical preparations for bronchodilation; pharmaceutical preparations for treatment of thyroid disorders; pharmaceutical preparations for treatment of hormonal disorders; Tablet preparations for medical purposes for treating Musculo skeletal pain, cancer, Psychiatric disorders, human immunodeficiency virus (HIV), Gastro Intestinal illnesses and disorders, allergies, viral illnesses, bacterial illnesses, gout, fungal infections, attention deficit disorder, immune disorders, neurological disorders and neurological illness, cardiovascular illnesses, urological issues, sleep disorders, sexual disorders, bronchodilation, thyroid disorders, hormonal disorders, and managing diabetes; gelatin capsule preparations for medical purposes for treating Musculo skeletal pain, cancer, Psychiatric disorders, human immunodeficiency virus (HIV), Gastro Intestinal illnesses and disorders, allergies, viral illnesses, bacterial illnesses, gout, fungal infections, attention deficit disorder, immune disorders, neurological disorders and neurological illness, cardiovascular illnesses, urological issues, sleep disorders, sexual disorders, bronchodilation, thyroid disorders, hormonal disorders, and managing diabetes; powder preparations for medical purposes for treating Musculo skeletal pain, cancer, Psychiatric disorders, human immunodeficiency virus (HIV), Gastro Intestinal illnesses and disorders, allergies, viral illnesses, bacterial illnesses, gout, fungal infections, attention deficit disorder, immune disorders, neurological disorders and neurological illness, cardiovascular illnesses, urological issues, sleep disorders, sexual disorders, bronchodilation, thyroid disorders, hormonal disorders, and managing diabetes; syrup preparations for medical purposes for treating Musculo skeletal pain, cancer, Psychiatric disorders, human immunodeficiency virus (HIV), Gastro Intestinal illnesses and disorders, allergies, viral illnesses, bacterial illnesses, gout, fungal infections, attention deficit disorder, immune disorders, neurological disorders and neurological illness, cardiovascular illnesses, urological issues, sleep disorders, sexual disorders, bronchodilation, thyroid disorders, hormonal disorders, and managing diabetes; cream preparations for medical purposes for treating Musculo skeletal pain, cancer, Psychiatric disorders, human immunodeficiency virus (HIV), Gastro Intestinal illnesses and disorders, allergies, viral illnesses, bacterial illnesses, gout, fungal infections, attention deficit disorder, immune disorders, neurological disorders and neurological illness, cardiovascular illnesses, urological issues, sleep disorders, sexual disorders, bronchodilation, thyroid disorders, hormonal disorders, and managing diabetes; oral solution preparations for medical purposes for treating Musculo skeletal pain, cancer, Psychiatric disorders, human immunodeficiency virus (HIV), Gastro Intestinal illnesses and disorders, allergies, viral illnesses, bacterial illnesses, gout, fungal infections, attention deficit disorder, immune disorders, neurological disorders and neurological illness, cardiovascular illnesses, urological issues, sleep disorders, sexual disorders, bronchodilation, thyroid disorders, hormonal disorders, and managing diabetes

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 14, 2026 EXRA
SOU EXTENSION 2 GRANTED
Feb 4, 2026 EX2G
SOU EXTENSION 2 FILED
Feb 4, 2026 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 4, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 8, 2025 EXRA
SOU EXTENSION 1 GRANTED
Jul 8, 2025 EX1G
SOU EXTENSION 1 FILED
Jul 8, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 8, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 18, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 24, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 24, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 18, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 3, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 3, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 3, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 3, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 3, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 30, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 30, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 30, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 2, 2024 GNRN
NON-FINAL ACTION E-MAILED
Aug 2, 2024 GNRT
NON-FINAL ACTION WRITTEN
Aug 2, 2024 CNRT
ASSIGNED TO EXAMINER
Jul 30, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 2, 2024 NWOS
NEW APPLICATION ENTERED
Jan 6, 2024 NWAP